BAJAJ FINSERV DIRECT LIMITED
Latest IPO Information

Dr. Agarwal's Health Care Ltd. IPO

IPO Date: Jan 29 to Jan 31 2025

Listing Date: Feb 4 2025

Objective

Our Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding of the following objects:
1. Repayment/prepayment, in part or full, of certain of our borrowings; and
2. General corporate purposes and unidentified inorganic acquisition

IPO Details

Face Value ₹ 1.00 Per Share
Issue Size ₹ 2044.70 - 2151.75 Cr
Price Band ₹ 382.00 - ₹ 402.00 Per Share
Market LOT 35 shares
Issue Type Book building

About Company

We provide a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations,diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceuticalproducts. We had a market share of approximately 25% of the total eye care service chain market in India during the FinancialYear 2024 (Source: CRISIL MI&A Report). With long-standing operational history, we endeavour to address all the needs ofour patients in their eye treatment journey through a network, which as of March 31, 2024, comprised 180 Faci .... lities. Read More
Address

6th Floor, Menon Eternity 1st Main Road, Austin Nagar Alwarpet

City

Chennai

State

Tamil Nadu

Pincode

600018

Phone

044-43787777

Email

secretarial@dragarwal.com

Website

www.dragarwals.co.in

About IPO

Listed At NSE/BSE
Lead Manager Motilal Oswal Investment Advisors Pvt Ltd
Promoters
Athiya Agarwal
Amar Agarwal
Agarwal’S Eye Institute
Anosh Agarwal
Ashvin Agarwal
Ashar Agarwal
Ashar Agarwal Family Trust
Anosh Agarwal Family Trust
Ashvin Agarwal Family Trust
Amar Agarwal Family Trust
Adil Agarwal Family Trust
Agarwals Eye Institute Pvt Ltd
Adil Agarwal

Promoter's Holding

Registrar

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

040 - 67162222/18003094001
einward.ris@kfintech.com
www.kfintech.com

Latest News

May
15
2026
EQUITY Posted on May 15th 2026

Dr. Agarwals Health Care informs about updates

Dr. Agarwals Health Care has informed that the Company is in receipt of a Show Cause Notice dated May 14, 2026 (SCN), from the Office of the Assistant Commissioner, GST & Central Excise, Nungambakkam, Chennai 600 034, alleging certain discrepancies in the returns / statements filed by the Company for the financial year 2022-23. The details as required in terms of regulation 30 read with Schedule III of the SEBI Listing regulations and the SEBI Master Circular concerning the aforesaid receipt of show cause notice, are enclosed as Annexure I. This information is also made available on the website of the Company at: https://dragarwals.co.in/dr-agarwals-health-care/#corporate-announcement.
The above information is a part of company’s filings submitted to BSE.
Read More
Mar
7
2026
EQUITY Posted on Mar 7th 2026

Dr. Agarwals Health Care informs about disclosures

Dr. Agarwals Health Care has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. Athiya Agarwal.
The above information is a part of company’s filings submitted to BSE.
Read More
Feb
27
2026
EQUITY Posted on Feb 27th 2026

Dr. Agarwals Health Care informs about disclosure

Dr. Agarwals Health Care has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Athiya Agarwal & Dr Anosh Agarwal.

The above information is a part of company’s filings submitted to BSE.

Read More
May
17
2026
COMPANY Posted on May 17th 2026

Amber Enterprises - Quaterly Results

The March 2026 quarter revenue stood at Rs. 28897.28 millions, up 7.85% as compared to Rs. 26794.57 millions during the corresponding quarter last year.Profit saw a slight increase of 5.90%to Rs. 842.86  millions from Rs. 795.92 millions.Operating Profit saw a handsome growth to 2091.61 millions from 2070.36 millions in the quarter ended March 2026.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 28897.28 26794.57 7.85 79669.53 67439.66 18.13 79669.53 67439.66 18.13
Other Income 115.93 153.95 -24.70 1068.56 818.10 30.61 1068.56 818.10 30.61
PBIDT 2091.61 2070.36 1.03 6009.67 5108.19 17.65 6009.67 5108.19 17.65
Interest 510.25 402.27 26.84 2275.89 1665.08 36.68 2275.89 1665.08 36.68
PBDT 1581.36 1668.09 -5.20 3677.14 3443.11 6.80 3677.14 3443.11 6.80
Depreciation 486.70 372.26 30.74 1749.20 1483.08 17.94 1749.20 1483.08 17.94
PBT 1094.66 1295.83 -15.52 1927.94 1960.03 -1.64 1927.94 1960.03 -1.64
TAX 251.80 499.91 -49.63 469.24 606.88 -22.68 469.24 606.88 -22.68
Deferred Tax 136.69 85.48 59.91 224.72 101.86 120.62 224.72 101.86 120.62
PAT 842.86 795.92 5.90 1458.70 1353.15 7.80 1458.70 1353.15 7.80
Equity 351.92 338.24 4.04 351.92 338.24 4.04 351.92 338.24 4.04
PBIDTM(%) 7.24 7.73 -6.32 7.54 7.57 -0.41 7.54 7.57 -0.41
Read More
May
17
2026
COMPANY Posted on May 17th 2026

Rolex Rings - Quaterly Results

The company witnessed a 7.68% growth in the revenue at Rs. 3056.92 millions for the quarter ended March 2026 as compared to Rs. 2838.87 millions during the year-ago period.The Net Loss for the quarter ended March 2026 is Rs. -1.49 millions as compared to Net Profit of Rs. 546.39 millions of corresponding quarter ended March 2025Operating Profit reported a sharp decline to 591.00 millions from 620.98 millions in the corresponding previous quarter.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 3056.92 2838.87 7.68 11434.95 11548.02 -0.98 11434.95 11548.02 -0.98
Other Income 28.72 98.83 -70.94 502.53 284.64 76.55 502.53 284.64 76.55
PBIDT 591.00 620.98 -4.83 2804.98 2690.89 4.24 2804.98 2690.89 4.24
Interest 3.57 11.32 -68.46 14.43 23.79 -39.34 14.43 23.79 -39.34
PBDT 95.48 609.66 -84.34 2274.14 2481.10 -8.34 2274.14 2481.10 -8.34
Depreciation 93.78 116.39 -19.43 371.25 404.20 -8.15 371.25 404.20 -8.15
PBT 1.70 493.27 -99.66 1902.89 2076.90 -8.38 1902.89 2076.90 -8.38
TAX 3.19 -53.12 -106.01 491.91 336.93 46.00 491.91 336.93 46.00
Deferred Tax 95.29 1.64 5710.37 139.09 -22.23 -725.69 139.09 -22.23 -725.69
PAT -1.49 546.39 -100.27 1410.98 1739.97 -18.91 1410.98 1739.97 -18.91
Equity 272.33 272.33 0.00 272.33 272.33 0.00 272.33 272.33 0.00
PBIDTM(%) 19.33 21.87 -11.62 24.53 23.30 5.27 24.53 23.30 5.27
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the issue size of Dr. Agarwal's Health Care Ltd. IPO?

The issue size of Dr. Agarwal's Health Care Ltd. IPO is ₹2044.70 - 2151.75 crore.

The Dr. Agarwal's Health Care Ltd. IPO opens for subscription on 2025-01-29 and closes on 2025-01-31.

The price range of Dr. Agarwal's Health Care Ltd. IPO is ₹382.00 to ₹402.00.

The lot size of Dr. Agarwal's Health Care Ltd. IPO is 35 shares.

The registrar of Dr. Agarwal's Health Care Ltd. IPO is K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.).

Dr. Agarwal's Health Care Ltd. IPO will be listed on NSE/BSE .

You will typically receive a confirmation message or notification from your broker or trading platform shortly after placing your IPO order. This confirms that your application has been submitted successfully. You can also check the order status in the IPO section of your trading account or app.

Apply early with valid UPI and PAN before 2025-01-31 to increase your chances.

The listing date of Dr. Agarwal's Health Care Ltd. IPO is 2025-02-04.

An Initial Public Offering (IPO) is when a private company sells shares to the public for the first time, enabling investors to purchase these shares and gain partial ownership in the business. For instance, if a well-known tech firm wants to grow and requires additional funds, it might choose to go public through an IPO. During this process, investors can buy shares, and the company’s stock starts trading on the stock exchange on the day of the IPO listing.

Investors can apply for an IPO through their bank or brokerage account. Many trading platforms have a specific section for IPOs where users can submit their applications online.

The primary market is where shares are offered to the public for the first time via an IPO. After the IPO, shares are traded on the secondary market (stock exchange), where existing shareholders can sell to new buyers.

Investing in an IPO offers the opportunity to become an early investor in companies with high growth potential, at a price which may be lower than their post-listing market value. It provides a chance to participate in the company's growth journey from its early stages. However, IPO investments also come with inherent risks, such as market volatility and uncertainties about the company's future performance.

The price of an IPO is established through a systematic process known as "book building." In this method, investors bid within a given price range, and the final price is set based on demand and market conditions. Several factors play a crucial role in determining the IPO price, including:

Past Financial Performance: Evaluating the company's revenue, profits, and financial stability over time

Growth Potential: Assessing future prospects based on the company's business model and market opportunities

Industry Peers: Comparing valuation metrics with similar companies in the same sector

Larger Industry Picture: Analysing overall industry trends and economic conditions that could impact the company's performance

The lock-in period for IPO shares refers to a duration during which specific investors are restricted from selling their shares post-listing. This period varies based on the type of investor:

Promoters: The lock-in period for promoters ranges from 6 months to 18 months, ensuring their commitment to the company's long-term growth

Anchor Investors: Typically, anchor investors face a shorter lock-in period of 30 to 90 days, depending on regulatory norms and the specific IPO

IPOs can be volatile and may not perform as expected in the short term. Investors risk losing capital if the stock price drops after listing, especially if the company does not meet its growth projections.

Information on upcoming IPOs is often available through brokerage platforms, financial news sites, and regulatory bodies like SEBI, which publishes details on companies going public. You can also get these details under the upcoming IPO section on Bajaj Markets.

Eligibility for an IPO typically includes:

Retail Investors: Individuals who invest in smaller amounts, usually under the “retail investor” category, with certain limits

Qualified Institutional Buyers (QIBs): Entities like mutual funds, banks, and insurance companies, who invest large sums

Non-Institutional Investors (NIIs): High-net-worth individuals or entities investing above the retail threshold

Investors must have a Demat and trading account to apply, and in some cases, certain financial or residency qualifications may apply depending on local regulations.

SME (Small and Medium Enterprise) IPOs generally carry higher risk but may provide significant growth potential. Investors should research the company’s stability, financials, and sector risks, as SME stocks can be more volatile compared to large-cap companies.

View More

Invalid Mobile Number

Invalid Full Name

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore